Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long- Term Extension Study in Patients with Rheumatoid Arthritis Magloire, A., Keystone, E., Taylor, P., Genovese, M., Schlichting, D., de la Torre, I., Beattie, S., Rooney, T. E M H SWISS MEDICAL PUBLISHERS LTD. 2015: 4S–5S

View details for Web of Science ID 000447700900009